- Corporate Officers - S
- Smith Cynthia
Insider Trading History of Smith Cynthia
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Smith Cynthia since 2015.
This trader's CIK number is 1609480.
At the time of last reporting, Smith Cynthia was the Director of Agios Pharmaceuticals, Inc.. (stock ticker symbol AGIO).
Also see all insider trading activities at Agios Pharmaceuticals, Inc..
Note that in the past
Smith Cynthia also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Agios Pharmaceuticals, Inc. (AGIO) by Smith Cynthia
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | AGIO | 0 | $0 | 0 | $0 | 4,422 | $0 |
| 2024 | AGIO | 0 | $0 | 0 | $0 | 5,690 | $0 |
| 2023 | AGIO | 0 | $0 | 0 | $0 | 2,302 | $0 |
Yearly summary of insider trading at Dicerna Pharmaceuticals Inc (DRNA) by Smith Cynthia
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2021 | DRNA | 0 | $0 | 0 | $0 | 3,333 | $0 |
Yearly summary of insider trading at Akebia Therapeutics, Inc. (AKBA) by Smith Cynthia
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2020 | AKBA | 0 | $0 | 4,567 | $55,260 | 0 | $0 |
| 2019 | AKBA | 15,000 | $52,800 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Zs Pharma, Inc. (ZSPH) by Smith Cynthia
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2015 | ZSPH | 0 | $0 | 0 | $0 | 9,155 | $100,009 |
Insider trading activities at 4 companies by Smith Cynthia:
1. Agios Pharmaceuticals, Inc. (AGIO)
2. Dicerna Pharmaceuticals Inc (DRNA)
3. Akebia Therapeutics, Inc. (AKBA)
4. Zs Pharma, Inc. (ZSPH)
Table 1. Insider trading of Agios Pharmaceuticals, Inc. (AGIO) by Smith Cynthia
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-08-11 | AGIO | Option Ex | 2,302 | .00 | 0 |
| 2025-06-20 | AGIO | Option Ex | 2,120 | .00 | 0 |
| 2024-08-11 | AGIO | Option Ex | 2,302 | .00 | 0 |
| 2024-06-13 | AGIO | Option Ex | 3,388 | .00 | 0 |
| 2023-08-11 | AGIO | Option Ex | 2,302 | .00 | 0 |
Table 2. Insider trading of Dicerna Pharmaceuticals Inc (DRNA) by Smith Cynthia
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2021-06-03 | DRNA | Option Ex | 3,333 | .00 | 0 |
Table 3. Insider trading of Akebia Therapeutics, Inc. (AKBA) by Smith Cynthia
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2020-06-08 | AKBA | Sale | 4,567 | 12.10 | 55,260 |
| 2019-11-20 | AKBA | Buy | 15,000 | 3.52 | 52,800 |
Table 4. Insider trading of Zs Pharma, Inc. (ZSPH) by Smith Cynthia
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2015-12-08 | ZSPH | Option Ex | 9,155 | 10.92 | 100,009 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Smith Cynthia
(Director of Agios Pharmaceuticals, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.